The transcription factor DDIT3 is a potential driver of dyserythropoiesis in myelodysplastic syndromes
Nerea Berastegui(Instituto de Salud Carlos III), Felipe Prósper(Clinica Universidad de Navarra)
Cited by 26
Related Papers
Deregulation of <i>FGFR1</i> and <i>CDK6</i> oncogenic pathways in acute lymphoblastic leukaemia harbouring epigenetic modifications of the <i>MIR9</i> family
|British Journal of Haematology|2011|60
Frequent and Simultaneous Epigenetic Inactivation of TP53 Pathway Genes in Acute Lymphoblastic Leukemia
|PLoS ONE|2011|57
Epigenetic-based differentiation therapy for Acute Myeloid Leukemia
|Nature Communications|2024|9
Novel epigenetic based differentiation therapy for Acute Myeloid Leukemia
|Research Square|2023|0